This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
|Articles|January 2, 2017
- Pharmaceutical Technology-01-02-2017
- Volume 41
- Issue 1
Fully Automated Capping Systems
The Thermo Scientific Decapper 500 and 550 series tube capping systems are fully automated capping systems for use in medium- to high-throughput biotech, pharmaceutical, and clinical laboratories doing compound storage, high-throughput screening, biobanking, and genomic storage.
The Thermo Scientific Decapper 500 and 550 series tube capping systems from Thermo Fisher Scientific and Hamilton Storage are fully automated capping systems for use in medium- to high-throughput biotech, pharmaceutical, and clinical laboratories doing compound storage, high-throughput screening, biobanking, and genomic storage. The systems allow users to cap and decap both Thermo Scientific Matrix and Nunc automation tubes without multiple pieces of equipment. The new decapper system features Quick Switch technology that allows users to transition between different tube and rack types. The systems can also cap and decap partial racks of tubes. The Decapper 550 provides additional functionality with its built-in barcode reader.
Articles in this issue
almost 10 years ago
Predicting Moisture Uptake in Solid Dosage Packagingalmost 10 years ago
Blister Packaging Moves Forwardalmost 10 years ago
Staffing and Preparation for Auditsalmost 10 years ago
Automatic Purge System for Control Panelsalmost 10 years ago
Spray Dryer for Efficient Microencapsulationalmost 10 years ago
Vials Reduce Risk of Drug Container Interactionsalmost 10 years ago
The Tide Stays Highalmost 10 years ago
Drug Quality Key to Innovation and Accessalmost 10 years ago
FDA New Drug Approvals Down Significantly in 2016almost 10 years ago
Beyond Distractions, Pharma Moves OnRelated to this article
Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Trending on Pharmaceutical Technology
1
France Remains One of Europe’s Leading Biotech Funding Hubs
2
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
3
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
4
PharmTech’s Weekly Roundup—November 6, 2026: Impurities, Supply Resilience, and AI Accountability
5